AN2 Therapeutics (ANTX) Stock Insights

ANTX price $4.46 +0.60 +15.54%

Ticker
ANTX
Price
$4.46
Change
+0.60 +15.54%
Market cap ?
$168.30M
P/E ?
-3.61
Dividend yield ?
0.00%
Beta ?
-0.98
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
69
Value
58
Quality
50
Growth
100

Stocklytics score rationale: value 58, quality 50, growth 100.

Financials

2019202020212022202320242025
0000000

AN2 Therapeutics, Inc. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of treatments for uncommon, long-term, and severe infectious conditions. A key focus of their pipeline is epetraborole, an investigational oral medication designed for once-daily administration to individuals battling chronic non-tuberculous mycobacterial lung disease. This enterprise was…

Fair value

ANTX fair value Not meaningful. Price $4.46.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare ANTX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.20——
2026-08-11-0.18-0.24——
2026-05-11-0.29-0.23——
2026-03-17-0.29-0.24——
2025-11-12-0.31-0.23——
2025-08-12-0.21-0.31——
2025-05-13-0.35-0.26——
2025-03-25-0.25-0.25——
2024-11-13-0.43-0.37——
2024-08-13-0.48-0.63——
2024-05-14-0.56-0.61——
2024-03-28-0.57-0.7180.00K—
2023-11-09-0.65-0.63——
2023-08-10-0.81-0.85——
2023-05-11-0.79-0.68——
2023-03-29-0.61-0.63——
2022-11-09-0.59-0.59——
2022-08-11-0.53-0.45——
2022-05-10-2.98-0.52——
2022-03-28-0.49———
2021-12-31-0.42———
2021-06-30-0.36———
2021-03-31-0.15———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency Quarterly.

Safety score 49/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividends were paid in 4 separate years. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
2018-01-11$0.66——Quarterly
2017-10-12$0.66——Quarterly
2017-07-12$0.66——Quarterly
2017-04-11$0.66——Quarterly
2017-01-11$0.66——Quarterly
2016-10-12$0.66——Quarterly
2016-07-13$0.66——Quarterly
2016-04-13$0.66——Quarterly
2016-01-13$0.66——Quarterly
2015-10-13$0.66——Quarterly
2015-07-13$0.58——Quarterly

Insider trades

DateInsiderActionSharesPriceValue
2026-10-12Marks Gilbert LynnBuy2.28K——
2026-10-12Martin Patricia A.Buy389——
2026-10-12Aziz KabeerBuy2.46K——
2026-09-15Trenor Cameron C. IIIBuy233.33K$5.361.25M
2026-09-15Trenor Cameron C. IIIBuy116.67K——
2026-09-09Readnour Robin ShaneSell585$6.023.52K
2026-09-09Readnour Robin ShaneSell523$6.023.15K
2026-09-08Readnour Robin ShaneSell5.29K$6.0231.86K
2026-09-08Readnour Robin ShaneSell4.72K$6.0228.44K
2026-09-03Readnour Robin ShaneSell3.22K$6.0719.56K
2026-09-03Readnour Robin ShaneSell2.88K$6.0717.46K
2026-09-01Williams Sarah JoanneSell272$5.531.50K
2026-09-01FitzPatrick Margaret MBuy2.10K$5.5311.60K
2026-08-24Trenor Cameron C. IIIOther0——
2026-08-17Readnour Robin ShaneSell18.71K$6.01112.39K
2026-08-17Readnour Robin ShaneSell16.70K$6.01100.31K
2026-08-14Zakrzewski Joseph SSell405.88K——
2026-07-10Aziz KabeerBuy2.85K——
2026-07-10Marks Gilbert LynnBuy2.79K——
2026-07-10Martin Patricia A.Buy766——
2026-07-08Eizen Joshua MSell5.95K$4.1724.80K
2026-05-29Williams Sarah JoanneSell265$4.431.17K
2026-04-10Aziz KabeerBuy3.77K——
2026-04-10Marks Gilbert LynnBuy3.77K——
2026-04-10Martin Patricia A.Buy1.19K——
2026-03-19Day LucyBuy82.30K$3.91321.79K
2026-03-19Day LucyBuy73.67K$3.91288.03K
2026-03-19Day LucyBuy66.00K$3.91258.06K
2026-03-19Day LucySell66.00K$17.281.14M
2026-03-19Day LucySell73.67K$6.60485.89K
2026-03-19Day LucySell82.30K$14.291.18M
2026-03-19Chanda SanjayBuy66.00K$3.91258.06K
2026-03-19Chanda SanjayBuy57.95K$3.91226.58K
2026-03-19Chanda SanjayBuy41.66K$3.91162.91K
2026-03-19Chanda SanjaySell66.00K$17.281.14M
2026-03-19Chanda SanjaySell57.95K$14.29828.11K
2026-03-19Chanda SanjaySell41.66K$6.60274.82K
2026-03-19Marks Gilbert LynnBuy23.74K$3.9192.83K
2026-03-19Marks Gilbert LynnBuy10.66K$3.9141.70K
2026-03-19Marks Gilbert LynnBuy10.36K$3.9140.52K
2026-03-19Marks Gilbert LynnSell10.36K$17.28179.06K
2026-03-19Marks Gilbert LynnSell10.66K$6.6070.35K
2026-03-19Marks Gilbert LynnSell23.74K$5.91140.32K
2026-03-19Aziz KabeerBuy23.74K$3.9192.83K
2026-03-19Aziz KabeerBuy20.72K$3.9181.03K
2026-03-19Aziz KabeerSell23.74K$5.91140.32K
2026-03-19Aziz KabeerSell20.72K$17.28358.11K
2026-03-19Martin Patricia A.Buy25.00K$3.9197.75K
2026-03-19Martin Patricia A.Buy23.74K$3.9192.83K
2026-03-19Martin Patricia A.Buy10.36K$3.9140.52K
2026-03-19Martin Patricia A.Sell10.36K$17.28179.06K
2026-03-19Martin Patricia A.Sell25.00K$6.60164.89K
2026-03-19Martin Patricia A.Sell23.74K$5.91140.32K
2026-03-19FitzPatrick Margaret MBuy23.74K$3.9192.83K
2026-03-19FitzPatrick Margaret MBuy11.46K$3.9144.82K
2026-03-19FitzPatrick Margaret MBuy10.36K$3.9140.52K
2026-03-19FitzPatrick Margaret MSell11.46K$18.24209.09K
2026-03-19FitzPatrick Margaret MSell10.36K$17.28179.06K
2026-03-19FitzPatrick Margaret MSell23.74K$5.91140.32K
2026-03-19Wong StephanieBuy25.00K$3.9197.75K
2026-03-19Wong StephanieBuy23.74K$3.9192.83K
2026-03-19Wong StephanieBuy10.36K$3.9140.52K
2026-03-19Wong StephanieSell25.00K$6.60164.89K
2026-03-19Wong StephanieSell10.36K$17.28179.06K
2026-03-19Wong StephanieSell23.74K$5.91140.32K
2026-03-19Zakrzewski Joseph SBuy100.00K$3.91391.00K
2026-03-19Zakrzewski Joseph SBuy23.74K$3.9192.83K
2026-03-19Zakrzewski Joseph SBuy10.36K$3.9140.52K
2026-03-19Zakrzewski Joseph SSell100.00K$6.60659.59K
2026-03-19Zakrzewski Joseph SSell10.36K$17.28179.06K
2026-03-19Zakrzewski Joseph SSell23.74K$5.91140.32K
2026-03-19Eizen Joshua MBuy92.00K$3.91359.72K
2026-03-19Eizen Joshua MBuy50.15K$3.91196.09K
2026-03-19Eizen Joshua MSell92.00K$17.881.64M
2026-03-19Eizen Joshua MSell50.15K$14.29716.64K
2026-03-19Spigelman Melvin KBuy23.74K$3.9192.83K
2026-03-19Spigelman Melvin KBuy16.94K$3.9166.24K
2026-03-19Spigelman Melvin KBuy10.36K$3.9140.52K
2026-03-19Spigelman Melvin KSell10.36K$17.28179.06K
2026-03-19Spigelman Melvin KSell23.74K$5.91140.32K
2026-03-19Spigelman Melvin KSell16.94K$9.31157.69K
2026-03-19Readnour Robin ShaneBuy23.74K$3.9192.83K
2026-03-19Readnour Robin ShaneBuy20.72K$3.9181.03K
2026-03-19Readnour Robin ShaneSell20.72K$17.28358.11K
2026-03-19Readnour Robin ShaneSell23.74K$5.91140.32K
2026-03-19Easom EricBuy267.65K$3.911.05M
2026-03-19Easom EricBuy250.00K$3.91977.50K
2026-03-19Easom EricBuy225.00K$3.91879.75K
2026-03-19Easom EricSell250.00K$6.601.65M
2026-03-19Easom EricSell225.00K$17.283.89M
2026-03-19Easom EricSell267.65K$11.993.21M
2026-03-03Williams Sarah JoanneSell327$1.06347
2026-02-20Eizen Joshua MBuy50.00K——
2026-02-20Eizen Joshua MBuy100.00K$1.04104.00K
2026-02-20Day LucyBuy38.00K——
2026-02-20Day LucySell77.00K$1.0480.08K
2026-02-20Williams Sarah JoanneBuy48.38K——
2026-02-20Easom EricBuy112.25K——
2026-02-20Easom EricBuy224.50K$1.04233.48K
2026-02-20Chanda SanjayBuy38.00K——

Institutional holders

Latest filed quarter: Q2 2026.

HolderSharesChangeChange %Value
VIVO CAPITAL, LLC3.15M00.00%15.26M
COMMODORE CAPITAL LP2.93M599.97K+25.71%14.20M
MILLENNIUM MANAGEMENT LLC2.32M96.19K+4.33%11.22M
BLACKROCK, INC.1.67M1.35M+422.48%8.06M
SPRUCE STREET CAPITAL LP1.66M00.00%8.04M
ALMITAS CAPITAL LLC1.47M-10.00K-0.68%7.11M
VANGUARD CAPITAL MANAGEMENT LLC1.24M227.63K+22.51%6.00M
ADAGE CAPITAL PARTNERS GP, L.L.C.1.00M00.00%4.84M
CITADEL ADVISORS LLC952.00K796.76K+513.25%4.61M
BOXER CAPITAL MANAGEMENT, LLC749.03K00.00%3.63M
GEODE CAPITAL MANAGEMENT, LLC697.81K411.26K+143.52%3.38M
SUMMITTX CAPITAL, L.P.597.45K597.45KNew2.89M
BALYASNY ASSET MANAGEMENT L.P.556.03K556.03KNew2.69M
STONEPINE CAPITAL MANAGEMENT, LLC551.69K-162.15K-22.72%2.67M
AMERIPRISE FINANCIAL INC537.06K-159.12K-22.86%2.60M
SIO CAPITAL MANAGEMENT, LLC529.93K-127.27K-19.37%2.56M
ALLY BRIDGE GROUP (NY) LLC526.32K00.00%2.55M
PROSIGHT MANAGEMENT, LP474.64K-41.12K-7.97%2.30M
WOODLINE PARTNERS LP459.81K-533.87K-53.73%2.23M
STATE STREET CORP311.60K196.40K+170.48%1.51M
NORTHERN TRUST CORP214.92K171.72K+397.55%1.04M
SEVEN FLEET CAPITAL MANAGEMENT LP208.95K9.24K+4.63%1.01M
VANGUARD FIDUCIARY TRUST CO196.92K59.21K+43.00%953.09K
VANGUARD PORTFOLIO MANAGEMENT LLC179.59K179.59KNew869.24K
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.167.45K-130.72K-43.84%810.44K

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

AN2 Therapeutics (ANTX) Stock Insights

ANTX$4.46+0.60 +15.54%

$168.30M

Market Cap

-3.61

P/E

—

Forward P/E

69

Score

Price History